Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis

Annual Review of Pharmacology and Toxicology

Volumn 35, Issue , 1995, Pages 93-127

  Wang, C C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African trypanosomes; mechanisms of drug action; targets for chemotherapy

Indexed keywords

ANTITRYPANOSOMAL AGENT; DIMINAZENE; EFLORNITHINE; ETHIDIUM; GLYCOPROTEIN; ISOMETAMIDIUM; MELARSOPROL; MESSENGER RNA; ORNITHINE DECARBOXYLASE INHIBITOR; PENTAMIDINE; SURAMIN;

AFRICAN TRYPANOSOMIASIS; DRUG ABSORPTION; DRUG MECHANISM; DRUG RESISTANCE; HUMAN; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROTEIN TRANSPORT; PURINE METABOLISM; REVIEW; RNA SPLICING;

PROTOZOA;

EID: 0028949538     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.35.1.93     Document Type: Review

References (176)

1. Hoare CA. 1972. The Trypanosomes of Mammals. A Zoological Monograph. Oxford: Blackwell
2. Jordan AM. 1986. Trypanosomiasis Control and African Rural Development, pp. 44-45. New York: Longman
3. Kuzoe FAS. 1993. Current situation of African trypanosomiasis. Acta Trop. 54: 153-62
4. 3a. Lumsden WHR, Evans DA, eds. 1976. Biology of the Kinetoplastida. London: Academic
5. Vickerman K. 1976. The diversity of kinetoplastid flagellates. See Ref. 3a, pp. 1-34
6. Bowman IBR, Flynn IW. 1976. Oxidative metabolism of trypanosomes. See Ref. 3a, pp. 435-76
7. Hill GC. 1976. Electron transport systems in kinetoplastida. Biochim. Biophys. Acta 465:149-93
8. Vickerman K. Tetley L, Hendry KAK, Turner CMR. 1988. Biology of African trypanosomes in the tsetse fly. Biol. Cell 64:109-19
9. Donelson JE. Rice-Ficht AC. 1985. Molecular biology of trypanosome antigenie variation. Microbiol. Rev. 49: 107-25
10. Miller EN, Turner MJ. 1981. Analysis of antigenic types appearing in first relapse populations of clones in Trypanosoma brucei. Parasitology 82:63-80
11. Kinabo LDB. 1993. Pharmacology of existing drugs for animal trypanosomiasis. Acta Trop. 54:169-83
12. Suryanarayana C, Gupta SL, Singh RP. 1985. Therapeutic and prophylactic effect of Tribexin prosalt and Gilpol against experimental Trypanosoma evansi infection in donkeys. Indian J. Vet. Med. 5:20-22
13. Zhang ZQ, Giroud C, Baltz T. 1991. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, Mel Cy, quinapyramine and isometamidium. Acta Trop. 50:101-10
14. Phillips MA, Coffino P, Wang CC. 1987. Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei: Implications for enzyme turnover and selective difluorornethylornithine inhibition. J. Biol. Chem. 262:8721-27
15. 13a. McCann PP, Sjoerdsma A, eds. 1987. Inhibition of Polyamine Metabolism, Biological Significance and Basis for New Therapies. New York: Academic
16. Bey P, Danzin C, Jung M. 1987. Inhibition of basic amino acid decarboxylases involved in polyamine biosynthesis. See Ref. 13a, pp. 1-31
17. Hawking F. 1978. Suramin with special reference to onchocerchiasis. Adv. Pharmacol. Chemother. 15:289-322
18. Vansterkenburg ELM, Coppens I, Wilting J, Bos OJM, Fischer MJE, et al. 1993. The uptake of the trypanocidal drug suramin in combination with lowdensity lipoproteins by Trypanosoma brucei and its possible mode of action. Acta Trop. 54:237-50
19. Fairlamb AH, Bowman IBR. 1980. Trypanosoma brucei maintenance of concentrated suspensions of bloodstream trypomastigotes in vitro using continuous dialysis for measurement of endocytosis. Exp. Parasitol. 49:366-80
20. Fairlamb AH, Bowman IBR. 1980. Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo. Mol. Biochem. Parasitol. 1:315-33
21. Misset O, Bos OJ, Opperdoes FR. 1986. Glycolytic enzymes of Trypanosoma brucei: Simultaneous purification, intraglycosomal concentrations and physical properties. Eur. J. Biochem. 157: 441-53
22. Hanggi D, Carr P. 1985. Analytical evaluation of the purity of commercial preparations of Cibacron Blue F3GA and related dyes. Anal. Biochem. 149:91-104
23. Jaffe JJ, McCormack JJ, Meymariam E. 1972. Comparative properties of schistosomal and filarial dihydrofolate reductases. Biochem. Pharmacol. 21:719-31
24. Chello PL, Jaffe JJ. 1972. Comparative properties of trypanosomal and mammalian thymidine kinases. Comp. Biochem. Physiol. B 43:543-62
25. Wilson M, Callens M, Kuntz DA. Perié J. Opperdoes FR. 1993. Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei. Mol. Biochem. Parasitol. 59:201-10
26. Wierenga RK, Swinkels B, Michels PAM, Osinga K, Misset O, et al. 1987. Common elements on the surface of glycolytic enzymes from Trypanosoma brucei may serve as topogenic signals for import into glycosomes. EMBO J. 6:215-21
27. Opperdoes FR, Borst P. 1977. Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: The glycosome. FEBS Lett. 80:360-64
28. Opperdoes FR, Baudhuin P, Coppens I, De Roe C, Edwards SW. 1984. Purification, morphomatric analysis and characterization of the glycosomes (microbodies) of the protozoan haemoflagellate. J. Cell Biol. 98:1178-84
29. Clarkson AB, Brohn FH. 1976. Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism. Science 194:204-6
30. Hart DT, Baudhuin P, Opperdoes FR, De Roe C. 1987. Biogenesis of the glycosome in Trypanosoma brucei: The synthesis, translocation and turnover of glycosomal polypeptides. EMBO J. 6: 1403-11
31. Clayton CE. 1987. Import of fructose biphosphate aldolase into the glycosomes of Trypanosoma brucei. J. Cell Biol. 105:2649-54
32. Neal RA. 1987. Experimental chemotherapy. In The Leishmaniases in Biology and Medicine. Clinical Aspects and Control, ed. W Peters. R Killick-Kendrick, 2:793-845. London: Academic
33. Sands M, Kron MA, Brown RB. 1985. Pentamidine: a review. Rev. Infect. Dis. 7:625-34
34. Kapusnik JE, Mills J. 1987. Pentamidine. In Antimicrobial Agents Annual, ed. PK Peterson, J Verhoef, 2:271-81. Amsterdam: Elsevier Sci.
35. Edwards KJ, Jenkins TC, Neidle S. 1992. Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA binding properties. Biochemistry 31:7104-9
36. Hajduk SL. 1978. Influence of DNA complexing compounds on the kinetoplast of trypanosomatids. Prog. Mol. Subcell. Biol. 6:158-200
37. Newton BA. 1974. The chemotherapy of trypanosomiasis and leishmaniasis: Towards a more rational approach. In Trypanosomiasis and Leishrnaniasis, pp. 285-307. Amsterdam: Elsevier/Excerpta Medica/North Holland
38. Delain E, Brack C, Riou G. Festy B. 1971. Ultrastructural alterations of Trypanosoma cruzi kinetoplast induced by the interaction of a trypanocidal drug (hydroxystilbamidine) with the kinetoplast DNA. J. Ultrastruct. Res. 37:200-18
39. Shapiro TA, Englund PT. 1990. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proc. Natl. Acad. Sci. USA 87: 950-54
40. Berger BJ, Carter NS, Fairlamb AH. 1993. Polyamine and pentamidine metabolism in African trypanosomes. Acta Trap. 54:215-24
41. Liu Y, Tidwell RR, Leibowitz MJ. 1994. Inhibition of in vitro splicing of a group I intron of Pneumocystis carinii. J. Eukaryot. Microbiol. 41:31-38
42. Cech TR. 1990. Self-splicing of group I introns. Annu. Rev. Biochem. 59:543-68
43. Dujon B. 1989. Group I introns as mobile genetic elements: facts and mechanistic speculations - a review. Gene 82: 91-114
44. Benne R. 1989. RNA editing in trypanosome mitochondria. Biochim. Biophys. Acta 1007:131-39
45. Blum B, Bakalara N, Simpson L. 1990. A model for RNA editing in kinetoplastid mitochondria: "Guide" RNA molecules transcribed from maxicircle DNA provide the edited information. Cell 60:189-98
46. Van der Spek H, Arts G-J, Zwaal RR, Van den Burg J.Sloof P, Benne R. 1991. Conserved genes encode guide RNAs in mitochondria of Crithidia fasciculata. EMBO J. 10:1217-24
47. Cech TR. 1991. RNA editing: world's smallest introns? Cell 64:667-69
48. Woodson SA, Cech TR. 1989. Reverse self-splicing of the Tetrahymena group I intron: implication for the directionality of splicing and for intron transposition. Cell 57:355-45
49. Agabian N. 1990. Trans splicing of nuclear pre-mRNAs. Cell 61:1157-60
50. Bruzik JP, Van Doren K. Hirsh D, Steitz JA. 1988. Trans splicing involves a novel form of small nuclear ribonucleoprotein particles. Nature 335:559-62
51. Damper D, Patton CL. 1976. Pentamidine transport and sensitivity in bruceigroup trypanosomes. J. Protozool. 23: 349-56
52. Flynn IW, Bowman IBR. 1974. The action of trypanocidal arsenical drugs on Trypanosoma brucei and Trypanosoma rhodesiense. Comp. Biochem, Physiol. B 48:261-73
53. Van Schaftingen E. Opperdoes FR, Hers H-G. 1987. Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose-2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei. Eur. J. Biochem. 166:653-61
54. Misset O, Van Beeumen J, Lambeir AA, van der Meer R, Opperdoes FR. 1987. Glyceraldehyde-phosphate dehydrogenase from Trypanosoma brucei: Comparison of the glycosomal and cytosolic isoenzymes. Eur. J Biochem. 162:501-7
55. Fairlamb AH, Henderson GB, Bacchi CJ, Cerami A. 1987. In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosma brucei. Mol Biochem. Parasitol. 24:185-91
56. Fairlamb AH, Carter NS, Cunningham M, Smith K. 1992. Characterization of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol 53:213-22
57. Cunningham ML, Zvelebil MJ, Fairlamb AH. 1994. Mechanism of inhibition of trypanothione reductase by trivalent organic arsenicals. Eur. J. Biochem. 221: 285-95
58. Johnston RM. 1963. The arsenicals. In Metabolic Inhibitors, ed. RM Hochster, JH Quastel, 2:99-118. New York/London: Academic
59. Carter NS, Fairlamb AH. 1993. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 361: 173-76
60. Hammond DJ. Gutteridge WE. 1984. Purine and pyrimidine metabolism in the Trypanosomatidae. Mol. Biochem. Parasitol. 13:243-61
61. Plagemann PGW, Wohlhueter RM, Woffendin C. 1988. Nucleoside and nucleobase transport in animal cells. Biochim. Biophys. Acta 947:405-43
62. Tabor CW, Tabor H. 1984. Polyamines. Annu. Rev. Biochem. 53:749-90
63. Schechter PJ, Sjoerdsma A. 1986. Difluoromethylornithine in the treatment of African trypanosomiasis. Parasitol. Today 23:223-24
64. Milord F, Pepin J, Loko L, Ethier L, Mpia B. 1992. Efficacy and toxicity of eflornithine for the treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet 340:652-55
65. Poulin R, Lu L, Ackermann B Bey P, Pegg AE. 1992. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by α-difluoromethylornithine: characterization of sequences at the inhibitor and coenzyme binding sites. J. Biol. Chem. 267:150-58
66. Hickok NJ. Seppnen PJ, Gunsalus G, Jänne OA. 1987. Complete amino acid sequence of human ornithine decarboxylase deduced from complementary DNA. DNA 6:179-87
67. Giffin BF, McCann PP, Bitonti AJ, Bacchi CJ. 1986. Polyamine depletion following exposure to DL-α-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei. J. Protozool. 33:238-43
68. Bitonti AJ, McCann PP, Sjoerdsma A. 1986. Necessity of antibody response in the treatment of African trypanosomiasis with α-difluromethylornithine. Biochem. Pharmacol. 35:331-34
69. Bacchi CJ, McCann PP. 1987. Parasitic protozoa and polyamines. See Ref. 13a, pp. 317-44
70. Phillips MA, Coffino P, Wang CC. 1988. Trypanosoma brucei ornithine decarboxylase: enzyme purification, characterization and expression in Escherichia coli. J. Biol. Chem. 263: 17933-41
71. Gupta M and Coffino P. 1985. Mouse ornithine decarboxylase. J. Biol. Chem. 260:2941-44
72. Rogers S, Wells R.Rechsteiner M. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364-68
73. Bacchi CJ, Yarlett N, Goldberg B, Bitonti AJ, McCann PP. 1991. Polyamine metabolism in African trypanosomes. In Biochemical Protozoology, ed. G Coombs, M North, pp. 469-81, London: Taylor & Francis
74. Gahl W A, Pilot HC. 1979. Putrescineoxidase activity in adult bovine serum and fetal bovine serum. In Vitro 15:252-57
75. Fairlamb AH, Henderson GB, Cerami A. 1989. Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proc. Natl. Acad, Sci. USA 86:2607-11
76. Bass KE, Sommer JM, Cheng Q-L, Wang CC. 1992. Mouse ornithine decarboxylase is stable in Trypanosoma brucei. J. Biol. Chem. 267:11034-37
77. Bayles JD, Harrison SM. Mbwabi DL, Schechter PJ. 1989. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Ann. Trop. Med. Parasitol. 83(Suppl. 1):111-14
78. Phillips MA, Wang CC. 1987. A Trypanosoma brucei mutant resistant to α-difluoromethylornithine. Mol. Biochem. Parasitol. 22:9-17
79. Bellofatto V, Fairlamb AH, Henderson GB, Cross GA. 1987. Biochemical changes associated with α-difluoromethylornithine uptake and resistance in Trypanosoma brucei. Mol. Biochem. Parasitol. 25:227-38
80. Browning CH, Morgan GT, Robb JUM, Walls LP. 1938. The trypanocidal action of certain phenanthridinium compounds, J. Pathol. Bacteriol. 46:203-4
81. Jensch H. 1955. 4,4′-Diaminodinodiazoaminobenzol, ein neues Mittel gegen Trypanosomen- und Babesien-Infectionen. Arzneim. Forsch. 5:634-35
82. Wragg WR, Washbown K, Brown KN, Hill J. 1958. Metamidium: a new trypanocidal drug. Nature 182:1005-6
83. MacGregor JT, Johnson IJ. 1977. In vitro metabolic activation of ethidium bromide and other phenanthridinium compounds: mutagenic activity in Salmonella typhimurium. Mutat. Res. 48: 103-7
84. Opperdoes FR. 1985. Biochemical peculiarities of trypanosomes, African and South American. Br. Med. Bull. 41:130-36
85. Fairlamb AH. 1990. Interaction of trypanocidal drugs with the metabolism and function of trypanothione. In Chemotherapy for Trypanosomiasis. Proc Workshop. Nairobi, Kenya. 1989, ed. AS Peregrine, pp. 25-31. Nairobi. Int. Lab. Res. Anim. Dis.
86. Scott JM. Pegram RG. 1974. A high incidence of Trypanosoma congolense strains resistant to homidium bromide in Ethiopia. Trop. Anim. Health Prod. 6:215-21
87. 1H-NMR studies on d(GCTTAAGC)2 and its complex with berenil. Eur. J. Biochem. 204:31-38
88. 2 in solution studied by NMR. Biochemistry 30:1372-85
89. Rushigajiki PKB, Mayende JSP, Guloba A, Wilson AJ. 1986. Maintenance of a herd of breeding cattle in an area of trypanosome challenge. Bull. Anim. Health Prod. Afr. 34:149-55
90. Osman AS, Jennings FW, Holmes PH. 1992. The rapid development of drug resistance by Trypanosoma evansi in immunusuppressed mice. Acta Trop. 50: 249-57
91. Ndoutamia G, Moloo SK, Murphy NB, Peregrine AS. 1993. Derivation and characterization of a quinapyramine-resislant clone of Trypanosoma congolense. Antimicrob. Agents Chemother. 37:1163-66
92. Peregrine AS, Mamman M. 1993. Pharmacology of diminazene: a review. Acta Trop. 54:185-204
93. Schonefeld A, Röttcher D, Moloo SK. 1987. The sensitivity to trypanocidal drugs of Trypanosoma vivax isolated in Kenya and Somalia. Trop. Med. Parasitol. 38:177-80
94. Kinabo LDB, Bogan JA. 1988. The pharmacology of isometamidium. J. Vet. Pharmacol. Ther. 11:233-45
95. Gimbi AA, Kinabo LDB. 1992. Influence of atropine on the acute toxicity of isometamidium. Vet. Hum. Toxicol. 34:398-400
96. Sutherland IA, Holmes PH. 1993. Alterations in drug transport in resistant Trypanosoma congolense. Acta Trop. 54:271-78
97. Brohn FH, Clarkson AB Jr. 1980. Trypanosoma brucei brucei: Patterns of glycolysis at 37°C in vitro. Mol. Biochem. Parasitol. 1:291-305
98. Visser N, Opperdoes FR, Borst P. 1981. Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei. Eur. J. Biochem. 118:521-26
99. Grant PT. Sargent JR. 1960. Properties of L-glycerol-3-phosphate oxidase and its role in respiration of Trypanosoma rhodesiense. Biochem. J. 76:229-37
100. Sommer JM. Wang CC. 1994. Targeting proteins to the glycosomes of African trypanosomes. Annu. Rev. Microbiol. 48:105-38
101. Osinga KA, Swinkels BW, Gibson WC, Borst P, Veeneman GH, et al. 1985. Topogenesis of microbody enzymes: a sequence comparison of the genes for the glycosome (microbody) and cytosolic phosphoglycerate kinases of Trypanosoma brucei. EMBO J. 4:3811-17
102. Clayton CE. 1985. Structure and regulated expression of genes encoding fructose biphosphate aldolase in Trypanosoma brucei. EMBO J. 4:2997-3003
103. Alexander K, Parsons M. 1991. A phosphoglycerate kinase-like molecule localized to glycosomal microbodies: evidence that the topogenic signal is not at the C-terminus. Mol. Biochem. Parasitol. 46:1-10
104. Michels PAM, Poliszczak A, Osinga KA, Misset O, Van Beaumen J, et al. 1986. Two tandemly linked identical genes code for the glycosomal glyceraldehyde-phosphate dehydrogenase in Trypanosoma brucei. EMBO J. 5:1049-56
105. Marchand M, Kooystra U, Wierenga RK, Lambeir AM, Van Beeumen J, et al. 1989. Glucosephosphate isomerase from Trypanosoma brucei: Cloning and characterization of the gene and analysis of the enzyme. Eur. J. Biochem. 184: 455-64
106. Swinkels BW, Gibson WG, Osinga KA, Kramer R, Veeneman Gil. et al. 1986. Characterization of the gene for the microbody (glycosomal) triosephosphate isomerase of Trypanosoma brucei. EMBO J. 5:1291-98
107. Kueng V, Schlaeppi K, Schneider A, Seebeck T. 1989. A glycosomal protein (p60) which is predominantly expressed in procyclic Trypanosoma brucei: Characterization and DNA sequence. J. Biol. Chem. 264:5203-9
108. Parsons M, Smith JM. 1989. Trypanosome glycosomal protein p60 is homologous to phosphoenolpyruvate carboxykinase (ATP). Nucleic Acids Res. 17: 6411
109. Broman K, Knupfer AL, Ropars M, Deshusses J. 1983. Occurrence and role of phosphoenolpyruvate carboxykinase in procyclic Trypanosoma brucei brucei glycosomes. Mol. Biochem. Parasitol. 8:79-87
110. Wierenga RK, Kalk KH, Hol WGJ. 1987. Structure determination of the glycosomal triosephosphate isomerase from Trypanosoma brucei at 2.4 Å resolution. J. Mol. Biol. 198:109-21
111. Vellieux FMD, Hajdu J, Verlinde CLMJ, Groendijk H, Read RJ, et al. 1993. Structure of glycosomal glyccraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data. Proc. Natl. Acad. Sci. USA 90:2355-59
112. Verlinde LMJ, Callens M, Van Calenbergh S, Van Aerschot A, Herdewijn P, et al. 1994. Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: towards new drugs for the treatment of sleeping sickness. J. Med. Chem. 37:3605-13
113. Visser N, Opperdoes FR. 1980. Glycolysis in Trypanosoma brucei. Eur. J. Biochem. 103:623-32
114. Evans DA, Brightman CJ, Holland MF. 1977. Salicylhydroxamic acid/glycerol in experimental trypanosomiasis. Lancet 2:769
115. van der Meer C, Versluijs-Broers JAM, Opperdoes FR. 1979. Trypanosoma brucei: Trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats. Exp. Parasitol. 48:126-34
116. Grady RW, Bienen EJ, Clarkson AB Jr. 1986. p-Alkyloxyhenzhydroxamic acids, effective inhibitors of the trypanosome glycerol-3-phosphate oxidase. Mol. Biochem. Parasitol. 19:231-40
117. Lee MGS, Van der Ploeg LHT. 1990. Homologous recombination and stable transfection in the parasitic protozoan Trypanosoma brucei. Science 250: 1583-87
118. Sommer JM, Cheng QL, Keller G-A, Wang CC. 1992. In vivo import of firefly luciferase into the glycosomes of Trypanosoma brucei and mutational analysis of the C-terminal targeting signal. Mol. Biol. Cell 3:749-59
119. Keller G-A, Gould S, Deluca M, Subramani S. 1987. Firefly luciferase is targeted to peroxisomes in mammalian cells. Proc. Natl. Acad. Sci. USA 84: 3264-68
120. Gould SJ, Keller G-A, Hosken N, Wilkinson J, Subramani S. 1989. A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108:1657-64
121. Gould SJ, Keller G-A, Subramani S. 1988. Identification of peroxisomal targeting signals located at the carboxy terminus of four peroxisomal proteins. J. Cell. Biol. 107:897-905
122. Fung K, Clayton CE. 1991. Recognition of a peroxisomal tripeptide entry signal by the glycosomes of Trypanosoma brucei. Mol. Biochem. Parasitol. 45: 261-64
123. Blattner J, Swinkels B, Dorsam H, Prospero T, Subramani S, Clayton CE. 1992. Glycosome assembly in trypanosomes: variations in the acceptable degeneracy of a COOH-terminal micro body targeting signal. J. Cell Biol. 119. 1129-36
124. Sommer JM, Peterson G, Keller G-A, Parsons M, Wang CC, 1993. The C-terminal tripeptide of glyosomal phosphoglycerate kinase is both necessary and sufficient for import into the glycosomes of Trypanosoma brucei. FEBS Lett. 316:153-58
125. Sommer JM, Nguyen IT, Wany CC 1994. Phosphoenolpyruate carboxykinase of Trypanosoma bracei is targeted to the glycosomes by a C-terminal sequence. FEBS Lett. 350:125-29
126. Swinkels BW, Gould SJ, Bodnar AG, Rachubinski RA, Subramani S. 1991. A novel, cleavable peroxisomal targeting signal at the amino-termnius of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10: 3255-66
127. Simon RJ, Kania RS, Zuckermann RN, Huebner VD, Jewell DA, et al. 1922. Peptoids: a modular approach to drug discovery. Proc. Natl. Acad. Sci. USA 89:9367-71
128. Eisenthal R, Game S, Holman GD. 1989. Specificity and kinetics of hexose transport in Trypanosoma brucei. Biochim. Biophys. Acta 985:81-89
129. Ter Kuile BH, Opperdoes FR. 1991. Glucose uptake by Trypanosoma brucei: Rate limiting steps in glycolysis and regulation of the glyolytic flux. J. Biol. Chem. 266:857-62
130. Bringaud F, Blatz T. 1993. Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei. Mol. Cell. Biol. 13:1146-54
131. Pays E, Coquelet H, Tebabi P, Pays A, Jefferies D, et al. 1990. Trypanosoma brucei: Constitutive activity of the VSG and procyclin gene promoters. EMBO J. 9:3145-51
132. Jefferies D, Tebabi P, Pays E. 1991. Transient activity assays of the Trypanosoma brucei variant surface glycoprotein gene promoter: control of gene expression at the post-transcriptional level. Mol. Cell. Biol. 11:338-43
133. Borst P. 1986. Discontinuous transcription and antigenic variation in trypanosomes. Annu. Rev. Biochem. 55:701-32
134. Pascolo H, Blonski C, Shire D, Toulmé JJ. 1993. Antisense effect of oligo-deoxynucleotides complementary to the mini-exon sequence of the protozoan parasite Lesihmania amazonensis. Biochimie 75:43-47
135. Matsukura M, Zon G, Shinozuka K, Robert-Guroff M, Shimada T, et al. 1989. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligo-deoxynucleotide against rev (art/trs) in chronically infected cells. Proc. Natl. Acad. Sci. USA 86:4244-48
136. Wang CC. 1991. A novel suicide inhibitor strategy for antiparasitic drug development. J. Cell. Biochem. 45:49-53
137. Ghoda L, van Daalen Weters T, Macrea M, Ascherman D, Coffino P. 1989. Prevention of rapid intracelluar degradation of ODC by a carboxy-terminal truncation. Science 243:14993-95
138. Ghoda L, Phillips MA, Bass KE, Wang CC, Coffino P. 1990. Trypanosome ornithine decarboxylase is stable because it lacks sequence found in the carboxyl-terminus of the mouse enzyme that is targeted for intracellular degradation. J. Biol. Chem. 265:11823-26
139. Bass KE, Wang CC. 1991. The in vitro differentiation of pleomorphic Trypanosoma brucei from bloodstream into procyclic form requires neither intermediary nor short-stumpy stage. Mol. Biochem. Parasitol. 44:261-70
140. Torri AF, Bertrand KI, Hajduk SL. 1993. Protein stability regulates the expression of cytochrome c during the developmental cycle of Trypanosoma brucei. Mol. Biochem. Parasitol. 57:305-16
141. Wong S, Campbell DA. 1989. A polyubiquitin gene from Trypanosoma brucei. Mol. Biochem. Parasitol. 37: 147-50
142. Wong S, Elgort MG, Gottesdiener K, Campbell DA. 1992. Allelic polymorphism of Trypanosoma brucei polyubiquitin gene. Mol. Biochem. Parasitol. 55:187-96
143. Lowrie DJ Jr, Giffin BF, Ventullo RM. 1993. The ubiquitin-ligase system in Trypanosoma brucei brucei. Am. J. Trop. Med. Hyg. 49:545-51
144. Murukami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, et al. 1992. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360:597-99
145. Fong WF, Heller JS, Canellakis ES. 1976. The appearnce of an ornithine decarboxylase inhibitory protein upon the addition of putrescine to cell culture. Biochim. Biophys. Acta 428:456-65
146. A cells. Biochem. J. 225: 689-97
147. Rechsteiner M, Hoffman L., Dubiel W. 1993. The multicatalytic and 26S proteses. J. Biol. 268:6065-68
148. Bitonti AJ, Kelley SE, McCann PP. 1984. Characterization of spermidine synthase from Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 13:21-28
149. Tekwani BL, Bacchi CJ, Pegg AE. 1992. Putrescine activated S-adenosylmethionine decarboxylase from Trypanosoma brucei brucei. Mol. Cell. Biochem. 117:53-61
150. Bitonti AJ, Byers TL, Bush TL, Casara PJ, Bacchi CJ, et al. 1990. Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase. Antimicrob. Agents Chemother. 34: 1485-90
151. Byers TL, Bush TL, McCann PP, Bitonti AJ. 1991. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine. Biochem. J. 274:527-33
152. Bacchi CJ, Nathan HC, Yarlett N, Goldberg B, McCann PP, et al. 1992. Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor. Antimicrob. Agents Chemother. 36: 2736-40
153. Byers TL, Casara P, Bitonti AJ. 1992. Uptake of the antitrypansomal drug 5′(Z-4-amino-2-butenyl) methylamino-5′-deoxyadenosine (MDL. 73811) by the purine transport system of Trypanosoma brucei brucei. Biochem. J. 283:755-58
154. Fairlamb AH, Cerami A. 1992. Metabolism and functions of trypanothione in the kinetoplastida. Annu. Rev. Microbiol. 46:695-729
155. Fairlamb AH, Henderson GB. 1987. Metabolism of trypanothione and glutathionylspermidine in trypanosomalids. In Host-Parasite Cellular and Molecular Interactions in Protozoal Infections, ed. K-P Chang, D Snary, pp. 29-40. Berlin: Springer-Verlag/NATO ASI Ser. Vol. H11
156. Aboagye-Kwarteng T, Smith K, Fairlamb AH. 1992. Molecular characterization of the trypanothione reductase gene from Crithidia fasciculata and Trypanosoma brucei: comparison with other flavoprotein disulfide oxidoreductases with respect to substrate specificity and catalytic mechanism. Mol. Microbiol. 6: 3089-99
157. Kuriyan J, Kong X-P, Krishna TSR, Sweet RM, Murgolo NJ, et al. 1991. X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4 Å resolution. Proc. Natl. Acad. Sci. USA 88:8764-68
158. 1-glulathionylspermidine disulfide at 0.28 nm resolution. Eur. J. Biochem. 213:67-75
159. Kelly JM, Taylor MC, Smith K, Hunter KJ, Fairlamb AH. 1993. Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which overexpress trypanothione reductase: sensitivity towards agents that are thought to induce oxidative stress. Eur. J. Biochem. 218: 29-37
160. Henderson GB, Ulrich P, Fairlamb AH, Rosenberg I, Pereira M, et al. 1988. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas' disease. Proc. Natl. Acad. Sci. USA 85:5374-78
161. Wang CC. 1984. Parasitic enzymes as potential targets for antiparasitic chemotherapy. J. Med. Chem. 27:1-9
162. Tuttle JV, Krenistsky TA. 1979. Purine phosphoribosyltransferases from Leishmania donovani. J. Biol. Chem. 255: 909-16
163. Nelson DJ, LaFon SW, Tuttle JV, Miller WH, Miller RL, et al. 1979. Allopurinol ribonucleoside as an antileishmanial agent. J. Biol. Chem. 254:11544-49
164. Marr JJ, Berens RL. 1983. Mini Review: pyrazolopyrimidine, metabolism in the pathogenic trypanosomatidae. Mol. Biochem. Parasitol. 7:339-56
165. Hitchings GH. 1975. Pharmacology of allopurinol. Arthritis Rheum. 18:863-70
166. Looker DL, Marr JJ, Berens RL. 1986. Mechanisms of action of pyrazolopyrimidines in Leishmania donovani. J. Biol. Chem. 261:9412-15
167. Kager PA, Rees PH, Wellde PT, Hockmeyer WT, Lyerly WH. 1981. Allopurinol in the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 75:556-59
168. Allen T, Ullman B. 1993. Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei. Nucleic Acids Res. 21:5431-38
169. Eads JC, Scapin G, Xu Y, Grubmeyer C, Sacchettini JC. 1994. The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP. Cell. 78:325-34
170. Ferguson MAJ, Cross GAM. 1984. Myristylation of the membrane form of a Trypanosoma brucei variant surface glycoprotein. J. Biol. Chem. 259:3011-15
171. Thomas JR, Dwek RA, Rademacher TW. 1990. Structure, biosynthesis, and function of glycosylphosphatidylinositols. Biochemistry 29:5413-22
172. Masterson WJ, Doering TL, Hart GW, Englund PT. 1989. A novel pathway for glycan assembly: biosynthesis of the glycosyl-phosphatidylinositol anchor of the trypanosome variant surface glycoprotein. Cell 56:793-800
173. Masterson WJ, Raper J, Doering TL, Hart GW, Englund PT. 1990. Fatty acid remodeling: a novel reaction sequence in the biosynthesis of trypanosome glycosyl phosphatidylinositol membrane anchors. Cell 62:73-80
174. Doering TL, Raper J, Buxbaum LU, Adams SP, Gordon JI, et al. 1991. An analog of myristic acid with selective toxicity for African trypanosomes. Science 252:1851-54
175. Bryant ML, Heuckeroth RO, Kimata JT, Ratner L, Gordon JI. 1989. Replication of human immodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc. Natl. Acad. Sci. USA 86:8655-59
176. Ring CS, Sun E, McKerrow JH, Lee GK, Rosenthal PJ, et al. 1993. Structure-based inhibitor design by using protein models for the development of anti-parasitic agents. Proc. Natl. Acad. Sci. USA 90:3583-87